Sunshine Biopharma Inc (SBFM)

Apr 01, 2025

Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus

Apr 01, 2025

Apr 01, 2025

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year - ACCESS Newswire

Apr 01, 2025

Apr 01, 2025

Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan

Apr 01, 2025

Apr 01, 2025

Sunshine Biopharma Inc. SEC 10-K Report - TradingView

Apr 01, 2025

Mar 28, 2025

Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView

Mar 28, 2025

Mar 25, 2025

Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance

Mar 25, 2025

Mar 24, 2025

Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN

Mar 24, 2025

Mar 24, 2025

Sunshine Biopharma to market new antibiotics in Canada - Investing.com India

Mar 24, 2025

Mar 24, 2025

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada - Yahoo Finance

Mar 24, 2025

Mar 24, 2025

Major Antibiotics Deal: Sunshine Biopharma Expands Portfolio in Billion-Dollar Market - Stock Titan

Mar 24, 2025

Mar 13, 2025

Sunshine Biopharma stock hits 52-week low at $2.01 By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Sunshine Biopharma stock hits 52-week low at $2.01 - Investing.com India

Mar 13, 2025

Mar 13, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 0.5% – Should You Sell? - Defense World

Mar 13, 2025

Mar 10, 2025

Sunshine Biopharma expands with new gastrointestinal drug By Investing.com - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Sunshine Biopharma expands with new gastrointestinal drug - Investing.com India

Mar 10, 2025

Mar 10, 2025

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market - ACCESS Newswire

Mar 10, 2025

Mar 10, 2025

Sunshine Biopharma Launches First of Two New Gastrointestinal Drugs in Canada - Stock Titan

Mar 10, 2025

Mar 04, 2025

Sunshine Biopharma stock hits 52-week low at $2.09 By Investing.com - Investing.com Australia

Mar 04, 2025

Mar 04, 2025

Sunshine Biopharma stock hits 52-week low at $2.09 - Investing.com India

Mar 04, 2025

Feb 17, 2025

A Look at Sunshine Biopharma Inc (SBFM) Shares in the Recent Past Indicates Growth - SETE News

Feb 17, 2025

Jan 28, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World

Jan 28, 2025

Jan 26, 2025

Sunshine Biopharma Announces Reverse Stock Split - ACCESS Newswire

Jan 26, 2025

Jan 26, 2025

Sunshine Biopharma Launches Two New Generic Prescription Drugs - ACCESS Newswire

Jan 26, 2025

Jan 25, 2025

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - ACCESS Newswire

Jan 25, 2025

Jan 25, 2025

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire

Jan 25, 2025

Jan 24, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 24, 2025

Jan 23, 2025

Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights

Jan 23, 2025

Jan 22, 2025

Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post

Jan 22, 2025

Jan 21, 2025

Sunshine Biopharma introduces new generic drugs in Canada - MSN

Jan 21, 2025

Jan 21, 2025

Sunshine Biopharma Appoints New Chief Commercial Officer - MSN

Jan 21, 2025

Jan 21, 2025

Sunshine Biopharma Launches Generic Mental Health Drug in Rapidly Growing Canadian Market - StockTitan

Jan 21, 2025

Jan 21, 2025

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT - Yahoo Finance

Jan 21, 2025

Jan 17, 2025

Sunshine Biopharma Appoints Michel Roy as Chief Commercial Officer - Defense World

Jan 17, 2025

Jan 15, 2025

Sunshine Biopharma appoints Michel Roy as CCO - MSN

Jan 15, 2025

Jan 15, 2025

Sunshine Biopharma names new Chief Commercial Officer By Investing.com - Investing.com South Africa

Jan 15, 2025

Jan 15, 2025

Sunshine Biopharma names new Chief Commercial Officer - Investing.com

Jan 15, 2025

Jan 15, 2025

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - WICZ

Jan 15, 2025

Dec 30, 2024

Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 14.6% in December - Defense World

Dec 30, 2024

Dec 11, 2024

Sunshine Biopharma Inc. Elects New Directors and Ratifies Appointment of Independent Registered Public Accounting Firm - Defense World

Dec 11, 2024

Dec 10, 2024

Sunshine Biopharma re-elects board, ratifies CPA firm By Investing.com - Investing.com Nigeria

Dec 10, 2024

Dec 10, 2024

Sunshine Biopharma re-elects board, ratifies CPA firm - Investing.com India

Dec 10, 2024

Dec 10, 2024

Sunshine Biopharma’s PLpro inhibitor shows activity in SARS-CoV-2 - BioWorld Online

Dec 10, 2024

Dec 09, 2024

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - AccessWire

Dec 09, 2024

Dec 09, 2024

Sunshine Biopharma's Novel COVID-19 Oral Treatment Shows Breakthrough Antiviral Activity in Preclinical Study - StockTitan

Dec 09, 2024

Dec 04, 2024

Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire

Dec 04, 2024